Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to $133.6 million.

  • CorMedix's Total Current Liabilities rose 62314.32% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.6 million, marking a year-over-year increase of 62314.32%. This contributed to the annual value of $33.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CorMedix's Total Current Liabilities is $133.6 million, which was up 62314.32% from $31.7 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Total Current Liabilities peaked at $133.6 million during Q3 2025, and registered a low of $3.0 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $18.3 million, with a median of $6.8 million in 2022.
  • Per our database at Business Quant, CorMedix's Total Current Liabilities plummeted by 4745.98% in 2021 and then skyrocketed by 62314.32% in 2025.
  • Over the past 5 years, CorMedix's Total Current Liabilities (Quarter) stood at $5.3 million in 2021, then increased by 18.07% to $6.3 million in 2022, then rose by 21.55% to $7.7 million in 2023, then soared by 341.14% to $33.8 million in 2024, then surged by 294.93% to $133.6 million in 2025.
  • Its last three reported values are $133.6 million in Q3 2025, $31.7 million for Q2 2025, and $34.4 million during Q1 2025.